These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8322670)

  • 1. Cholesterol embolization syndrome after intravenous tissue plasminogen activator for acute myocardial infarction.
    Arora RR; Magun AM; Grossman M; Katz J
    Am Heart J; 1993 Jul; 126(1):225-8. PubMed ID: 8322670
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue plasminogen activator in pediatric myocardial infarction.
    Krendel S; Pollack P; Hanly J
    Ann Emerg Med; 2000 May; 35(5):502-5. PubMed ID: 10783412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol crystal embolization-associated renal failure after therapy with recombinant tissue-type plasminogen activator.
    Gupta BK; Spinowitz BS; Charytan C; Wahl SJ
    Am J Kidney Dis; 1993 Jun; 21(6):659-62. PubMed ID: 8503421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cholesterol crystal embolization after intravenous thrombolysis by anistreplase for suspected myocardial infarction].
    Coppere B; Granade G; Girard-Madoux MH; Claudel JP; Kruszynski G; Porte J; Gayral M; Ninet J
    Presse Med; 1992 Dec; 21(42):2061. PubMed ID: 1294983
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cholesterol embolization after intravenous streptokinase therapy in acute myocardial infarction].
    Bucher A; Roald B
    Tidsskr Nor Laegeforen; 1993 Jun; 113(15):1844-5. PubMed ID: 8322322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. t-PA therapy in acute myocardial infarction.
    Giebel RA; Pavey SS; Bryant PP
    J Emerg Nurs; 1988; 14(4):206-13. PubMed ID: 3137387
    [No Abstract]   [Full Text] [Related]  

  • 7. Cholesterol embolization syndrome following thrombolytic therapy with streptokinase and tissue plasminogen activator.
    Ben-Chitrit S; Korzets Z; Hershkovitz R; Bernheim J; Schneider M; Bernheim J
    Nephrol Dial Transplant; 1994; 9(4):428-30. PubMed ID: 8084460
    [No Abstract]   [Full Text] [Related]  

  • 8. Paraplegia subsequent to administration of tissue plasminogen activator and intravenous heparin following myocardial infarction--a case report.
    DePorto R; Ahn JH; Gianutsos JG
    J Spinal Cord Med; 2000; 23(2):150-2. PubMed ID: 10914357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cholesterol crystal embolisms due to systemic thrombolysis of an acute myocardial infarct].
    Diethelm A; Vorburger C; Anabitarte M; Haag E
    Schweiz Med Wochenschr; 1994 Aug; 124(33):1437-41. PubMed ID: 7939511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case history: successful thrombolytic therapy in a patient with acute myocardial infarction.
    Sait YR
    Heart Lung; 1988 Nov; 17(6 Pt 2):782-6. PubMed ID: 3142824
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant tissue plasminogen activator (rt-PA): is it the thrombolytic agent of choice for an evolving acute myocardial infarction?
    Sherry S
    Am J Cardiol; 1987 Apr; 59(9):984-9. PubMed ID: 3105303
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostaglandin E1 does not accelerate rTPA-induced thrombolysis in acute myocardial infarction.
    Kleiman NS; Tracy RP; Schaaff LJ; Harris S; Hill RD; Puleo P; Roberts R
    Am Heart J; 1994 Apr; 127(4 Pt 1):738-43. PubMed ID: 8154410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intravenous SM-9527 (double-chain tissue plasminogen activator) on left ventricular function in the chronic stage of acute myocardial infarction.
    Hayashi H; Takatsu F; Sone T; Mizutani N; Hirayama H; Osugi J; Yamauchi K; Ogawa H; Watanabe T; Saito H
    Clin Cardiol; 1993 May; 16(5):409-14. PubMed ID: 8504575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylactoid reaction during an infusion of recombinant tissue-type plasminogen activator for acute myocardial infarction.
    Massel D; Gill JB; Cairns JA
    Can J Cardiol; 1991 Sep; 7(7):298-302. PubMed ID: 1933636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous thrombolytic therapy with a combination of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator in acute myocardial infarction.
    Bode C; Schuler G; Nordt T; Schönermark S; Baumann H; Richardt G; Dietz R; Gurewich V; Kübler W
    Circulation; 1990 Mar; 81(3):907-13. PubMed ID: 2106403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appraisal of various thrombolytic agents in the treatment of acute myocardial infarction.
    Sherry S
    Am J Med; 1987 Aug; 83(2A):31-46. PubMed ID: 3115099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of a single intravenous bolus injection of tissue-type plasminogen activator in acute myocardial infarction. Bolus Dose-Escalation Study of Tissue-Type Plasminogen Activator (BEST) Investigators.
    Hackett D; Andreotti F; Haider AW; Brunelli C; Shahi M; Fussell A; Buller N; Foale R; Lipkin D; Caponnetto S
    Am J Cardiol; 1992 Jun; 69(17):1393-8. PubMed ID: 1590225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue plasminogen activator: hospital experience.
    LiMandri G; Dunn D; Burd C; Gregory J
    N J Med; 1991 Aug; 88(8):561-5. PubMed ID: 1922986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Death or nonfatal stroke in patients with acute myocardial infarction treated with tissue plasminogen activator. Participants in the National Registry of Myocardial Infarction 2.
    Angeja BG; Rundle AC; Gurwitz JH; Gore JM; Barron HV
    Am J Cardiol; 2001 Mar; 87(5):627-30, A9. PubMed ID: 11230850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator.
    Loscalzo J; Braunwald E
    N Engl J Med; 1988 Oct; 319(14):925-31. PubMed ID: 3138537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.